International Symposium on Oncology, Immunotherapy and Biomarkers ISOIB

Call For Papers

The ISOIB bridges the gap between academia and industry by promoting research with practical applications. It provides a platform for professionals and researchers to share insights that drive real-world impact.

The conference focuses on Oncology , encouraging applied research, case studies, and industry-driven innovations.

Authors are invited to submit papers addressing, but not limited to, the following areas:

Biomarkers in cancer diagnosis and treatment

Immunotherapy and its clinical applications

Role of precision medicine in oncology

Emerging trends in cancer immunotherapy

Biomarker discovery and validation

Challenges in immunotherapy implementation

Patient selection for immunotherapy

Combination therapies with immunotherapy

Ethical issues in biomarker research

Impact of biomarkers on treatment outcomes

Innovative technologies in biomarker analysis

Clinical trials for immunotherapeutic agents

Role of the immune system in cancer

Biomarkers for early cancer detection

Patient perspectives on immunotherapy

Regulatory considerations for biomarker use

Future directions in immunotherapy research

Collaboration between academia and industry

Health disparities in access to immunotherapy

Integrating biomarkers into clinical practice

Submissions will be evaluated based on applicability, innovation, and research contribution. Accepted papers will be presented and considered for publication in reputed journals and conference proceedings.

Registration

Complete your registration to participate in discussions that bridge academia and industry, and gain exposure to practical insights.

👉 Confirm Your Participation Today

Publication

Selected papers will be considered for publication platforms that support academic and industry collaboration.

👉 Submit Your Paper Now

Hybrid Event